Serina Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SER research report →
About the company
Serina Therapeutics, Inc. , a biotechnology firm, focuses on creating pharmaceutical treatments for neurological conditions and pain. Its primary investigational drug, SER 252, is a POZ conjugate intended for managing Parkinson's disease.
- CEO
- Steven A. Ledger
- IPO
- 2000
- Employees
- 12
- HQ
- Huntsville, AL, US
Price Chart
- Market Cap
- $20.58M
- P/E
- -0.96
- P/S
- 158.33
- P/B
- 1.30
- EV/EBITDA
- 0.04
- Div Yield
- 0.00%
- Gross Margin
- 73.85%
- Op Margin
- -18803.08%
- Net Margin
- -16359.23%
- ROE
- -402.16%
- ROIC
- -116.63%
- Revenue
- $0 · -100.00%
- Net Income
- $-19,182,000 · -72.17%
- EPS
- $-1.91 · -26.49%
- Op Income
- $-24,022,000
- FCF YoY
- -4.64%
- 52W High
- $7.92
- 52W Low
- $1.22
- 50D MA
- $1.83
- 200D MA
- $2.84
- Beta
- 0.03
- Avg Volume
- 109.56K
Get TickerSpark's AI analysis on SER
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 17, 26 | Venkatesan Jay | other | 224,152 |
| Jun 17, 26 | Venkatesan Jay | other | 15,250 |
| May 22, 26 | Venkatesan Jay | buy | 589 |
| Jun 17, 26 | Venkatesan Jay | other | 96,525 |
| Jun 17, 26 | Bailey Gregory | other | 6,666,667 |
| Jun 17, 26 | Bailey Gregory | other | 3,333,333 |
| Jun 17, 26 | Bailey Gregory | other | 1,770,805 |
| Jun 17, 26 | Bailey Gregory | other | 15,250 |
| Jun 17, 26 | Bailey Gregory | other | 762,548 |
| Jun 17, 26 | Brannan Stephen K. | other | 15,250 |
Our SER coverage
Recent articles, reports, and earnings notes.
No research on SER yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SER report →Similar companies
Peers in the same neighborhood.